Trial intelligence / Profile preview

Propofol versus isoflurane and perioperative blood glucose in type 2 diabetes

IRCT20170716035104N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Apr 2017
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Isoflurane group with Propofol group (2 arms). Primary endpoint: Blood glucose level before and after surgery. Started Apr 2017; status: completed.

02

Drugs

propofolisoflurane
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on IRCT20170716035104N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170716035104N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call